Polymerase Chain Reaction (PCR) Market Report 2022 is the latest study published by Gravitas Market Insights. It offers global Product analysis for 2016-2021 and valuates opportunities and forecast data for 2022-2028. This report covers Market Overview along with market background, Market Trends, Demand Analysis, Analysis of COVID-19 Impact, Segment Overview, Regional Profiling, Overall market structure and in-depth Competitive Analysis. Additionally, key activities related to the market strategies which includes mergers and acquisitions, product advancements, etc., are discussed.
In this report, the Global Polymerase Chain Reaction (PCR) market is valued at USD 7.57 Billion in 2021 and is projected to growing at a CAGR of 9.1% during the period 2022 to 2028. In the end, the report introduced new project SWOT analysis, investment feasibility analysis, and investment return analysis.
Polymerase Chain Reaction (PCR) Report by Type, Product Type, Indication, End User and Geography – Global Forecast to 2028 is a professional and comprehensive research report on the world’s major regional market conditions, focusing on the main regions i.e., North America, Europe, Asia-Pacific, Southeast Asia, and Middle East Africa)
Polymerase Chain Reaction (PCR) Market Segmentation:
By Type:
- Standard PCR
- Real-time PCR
- Digital PCR
By Product Type:
- Instruments
- Reagents & Consumables
By Indication:
- Oncology
- Infectious Disease
- Genetic disorder
- Other Indication
By End User:
- Academics & Research Organization
- Hospitals & Clinics
- Speciality clinics
- Others
Regional Coverage
- North America
- United States
- Canada
- Mexico
- Europe
- UK
- Germany
- France
- Italy
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Korea
- Australia
- Southeast Asia
- Rest of Asia-Pacific
- South America
- Brazil
- Argentina
- Colombia
- Rest of South America
- Middle East & Africa
- GCC
- South Africa
- Rest of Middle East & Africa
Competitive Analysis:
Eminent market players have been outlined to extract improved insights into the worldwide businesses. Our research reports offer all-inclusive information on various topmost manufacturers that are operational across global regions. We provide company profiles which include detailed overview of the company, business information, business performance, crucial strategies implemented through the years.
Few of the Key Players Covered in Our Report:
- Abbott
- BIO-RAD LABORATORIES, INC.
- THERMO FISHER SCIENTIFIC, INC.
- QIAGEN
- AGILENT TECHNOLOGIES, INC.
- CYTIVA (GE HEALTHCARE)
- F. HOFFMANN-LA ROCHE LTD.
- BIOMÉRIEUX SA
- DANAHER CORPORATION
- STILLA
- MICROSYNTH AG
- FLUIDIGM CORPORATION
- JN MEDSYS
Impact of COVID19:
The COVID19 pandemic crippled the global economy, it resulted in a worldwide lockdown, and this has majorly impacted numerous industries. Our Product experts are working round-the-clock to identify, accumulate and in-time deliver market analysis because of unprecedented decisions in COVID-19 repercussions on many businesses. The full version of this report will comprise the overall impact of the pandemic and predicted alteration on the outlook of the Product, by taking into the account the economic, political, technological, and social parameters.
This research study involves broad usage of both secondary and primary data sources. The research process involves the identification of numerous factors which affect the industry, comprising the market environment, government policy, historical data, present trends in the market, competitive landscape, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges.
Market Estimation
Top-down and bottom-up approaches are used for validating the market size for companies, regional segments along with relevant market segmentations such as product type and application.
This report includes market estimations which are based on the marketed sale price of a product. Further breakdown of product segments, particular market share are formed based on the weightage assigned to every segment, which is derived of their usage rate and average price. The entire probable factors which effect the markets and influence them in a great way are included in this research report; and have been accounted for, studied in-depth and are confirmed through primary research. These are then studies to get the final qualitative and quantitative data. Any of the factors such as the outcome of inflation, economic downfall, and any kind of policy and regulatory alterations and/or other such factors are not accounted for in the market forecast. All of this data is amalgamated and included with thorough inputs and analysis from Gravitas Market Insights is curated in this report.
Along with the previously mentioned approaches, various data triangulation methods, in order to conduct market estimations and market forecasting for the complete market segments are detailed in this report. Key Companies present in the said market are also acknowledged via in-depth secondary research and primary research.
Section 1: Executive Summary
1.1. Polymerase Chain Reaction (PCR) Market Industry 360° outline, Year 2016 – 2028
1.2. Business Model Trends
1.3. Growth Trends
1.4. End-User/Product Type Trends
1.5. Regional Trends
Section 2: Market Dynamics - Polymerase Chain Reaction (PCR) Market Industry Insights
2.1. Growth Drivers
2.2. Opportunities
2.3. Industry challenges
2.4. SWOT Analysis
2.5. Porter’s Analysis
2.6. Worldwide Industry Landscape, Year 2016 – 2028
2.7. Industry Segmentation
2.8. Technology & Invention landscape
2.9. Regional Landscape
2.9.1. North America
2.9.2. Europe
2.9.3. Asia-Pacific
2.9.4. South America
2.9.5. Middle East & Africa
2.10. Competitive Environment
Section 3: Global Polymerase Chain Reaction (PCR) Market, By Type
3.1. Segmentation Analysis, By Type, 2016-2028
3.2. Market Share Segmentation Analysis, By Type, 2016-2028
3.3. Standard PCR
3.3.1. Market estimates and forecast with Growth rate analysis, 2016 – 2028
3.4. Real-time PCR
3.4.1. Market estimates and forecast with Growth rate analysis, 2016 – 2028
3.5. Digital PCR
3.5.1. Market estimates and forecast with Growth rate analysis, 2016 – 2028
Section 4: Global Polymerase Chain Reaction (PCR) Market, By Product Type
4.1. Segmentation Analysis, By Product Type, 2016-2028
4.2. Market Share Segmentation Analysis, By Product Type, 2016-2028
4.3. Instruments
4.3.1. Market estimates and forecast with Growth rate analysis, 2016 – 2028
4.4. Reagents & Consumables
4.4.1. Market estimates and forecast with Growth rate analysis, 2016 – 2028
Section 5: Global Polymerase Chain Reaction (PCR) Market, By Indication
5.1. Segmentation Analysis, By Indication, 2016-2028
5.2. Market Share Segmentation Analysis, By Indication, 2016-2028
5.3. Oncology
5.3.1. Market estimates and forecast with Growth rate analysis, 2016 – 2028
5.4. Infectious Disease
5.4.1. Market estimates and forecast with Growth rate analysis, 2016 – 2028
5.5. Genetic disorder
5.5.1. Market estimates and forecast with Growth rate analysis, 2016 – 2028
5.6. Other Indication
5.6.1. Market estimates and forecast with Growth rate analysis, 2016 – 2028
Section 6: Global Polymerase Chain Reaction (PCR) Market, By End Use
6.1. Segmentation Analysis, By End Use, 2016-2028
6.2. Market Share Segmentation Analysis, By End Use, 2016-2028
6.3. Academics & Research Organization
6.3.1. Market estimates and forecast with Growth rate analysis, 2016 – 2028
6.4. Hospitals & Clinics
6.4.1. Market estimates and forecast with Growth rate analysis, 2016 – 2028
6.5. Speciality clinics
6.5.1. Market estimates and forecast with Growth rate analysis, 2016 – 2028
6.6. Others
6.6.1. Market estimates and forecast with Growth rate analysis, 2016 – 2028
Section 7: Global Polymerase Chain Reaction (PCR) Market, Regional Analysis
7.1. Global Polymerase Chain Reaction (PCR) Market, Regional Analysis
7.2. North America, Country level Analysis
7.2.1. North America Polymerase Chain Reaction (PCR) Market estimates and forecast with Growth rate analysis, By Type, 2016 – 2028
7.2.2. North America Polymerase Chain Reaction (PCR) Market estimates and forecast with Growth rate analysis, By Product Type, 2016 – 2028
7.2.3. North America Polymerase Chain Reaction (PCR) Market estimates and forecast with Growth rate analysis, By Indication, 2016 – 2028
7.2.4. North America Polymerase Chain Reaction (PCR) Market estimates and forecast with Growth rate analysis, By End Use, 2016 – 2028
7.2.5. United States
7.2.5.1. Market estimates and forecast with Growth rate analysis, 2016 – 2028
7.2.6. Canada
7.2.6.1. Market estimates and forecast with Growth rate analysis, 2016 – 2028
7.2.7. Mexico
7.2.7.1. Market estimates and forecast with Growth rate analysis, 2016 – 2028
7.3. Europe Country level Analysis
7.3.1. Europe Polymerase Chain Reaction (PCR) Market estimates and forecast with Growth rate analysis, By Type, 2016 – 2028
7.3.2. Europe Polymerase Chain Reaction (PCR) Market estimates and forecast with Growth rate analysis, By Product Type, 2016 – 2028
7.3.3. Europe Polymerase Chain Reaction (PCR) Market estimates and forecast with Growth rate analysis, By Indication, 2016 – 2028
7.3.4. Europe Polymerase Chain Reaction (PCR) Market estimates and forecast with Growth rate analysis, By End Use, 2016 – 2028
7.3.5. UK
7.3.5.1. Market estimates and forecast with Growth rate analysis, 2016 – 2028
7.3.6. Germany
7.3.6.1. Market estimates and forecast with Growth rate analysis, 2016 – 2028
7.3.7. France
7.3.7.1. Market estimates and forecast with Growth rate analysis, 2016 – 2028
7.3.8. Italy
7.3.8.1. Market estimates and forecast with Growth rate analysis, 2016 – 2028
7.3.9. Spain
7.3.9.1. Market estimates and forecast with Growth rate analysis, 2016 – 2028
7.3.10. Russia
7.3.10.1. Market estimates and forecast with Growth rate analysis, 2016 – 2028
7.3.11. Rest of Europe
7.3.11.1. Market estimates and forecast with Growth rate analysis, 2016 – 2028
7.4. Asia-Pacific Country level Analysis
7.4.1. Asia-Pacific Polymerase Chain Reaction (PCR) Market estimates and forecast with Growth rate analysis, By Type, 2016 – 2028
7.4.2. Asia-Pacific Polymerase Chain Reaction (PCR) Market estimates and forecast with Growth rate analysis, By Product Type, 2016 – 2028
7.4.3. Asia-Pacific Polymerase Chain Reaction (PCR) Market estimates and forecast with Growth rate analysis, By Indication, 2016 – 2028
7.4.4. Asia-Pacific Polymerase Chain Reaction (PCR) Market estimates and forecast with Growth rate analysis, By End Use, 2016 – 2028
7.4.5. China
7.4.5.1. Market estimates and forecast with Growth rate analysis, 2016 – 2028
7.4.6. India
7.4.6.1. Market estimates and forecast with Growth rate analysis, 2016 – 2028
7.4.7. Japan
7.4.7.1. Market estimates and forecast with Growth rate analysis, 2016 – 2028
7.4.8. Korea
7.4.8.1. Market estimates and forecast with Growth rate analysis, 2016 – 2028
7.4.9. Australia
7.4.9.1. Market estimates and forecast with Growth rate analysis, 2016 – 2028
7.4.10. Southeast Asia
7.4.10.1. Market estimates and forecast with Growth rate analysis, 2016 – 2028
7.4.11. Rest of Asia-Pacific
7.4.11.1. Market estimates and forecast with Growth rate analysis, 2016 – 2028
7.5. South America Country level Analysis
7.5.1. South America Polymerase Chain Reaction (PCR) Market estimates and forecast with Growth rate analysis, By Type, 2016 – 2028
7.5.2. South America Polymerase Chain Reaction (PCR) Market estimates and forecast with Growth rate analysis, By Product Type, 2016 – 2028
7.5.3. South America Polymerase Chain Reaction (PCR) Market estimates and forecast with Growth rate analysis, By Indication, 2016 – 2028
7.5.4. South America Polymerase Chain Reaction (PCR) Market estimates and forecast with Growth rate analysis, By End Use, 2016 – 2028
7.5.5. Brazil
7.5.5.1. Market estimates and forecast with Growth rate analysis, 2016 – 2028
7.5.6. Argentina
7.5.6.1. Market estimates and forecast with Growth rate analysis, 2016 – 2028
7.5.7. Colombia
7.5.7.1. Market estimates and forecast with Growth rate analysis, 2016 – 2028
7.5.8. Rest of South America
7.5.8.1. Market estimates and forecast with Growth rate analysis, 2016 – 2028
7.6. Middle East & Africa Country level Analysis
7.6.1. MEA Polymerase Chain Reaction (PCR) Market estimates and forecast with Growth rate analysis, By Type, 2016 – 2028
7.6.2. MEA Polymerase Chain Reaction (PCR) Market estimates and forecast with Growth rate analysis, By Product Type, 2016 – 2028
7.6.3. MEA Polymerase Chain Reaction (PCR) Market estimates and forecast with Growth rate analysis, By Indication, 2016 – 2028
7.6.4. MEA Polymerase Chain Reaction (PCR) Market estimates and forecast with Growth rate analysis, By End Use, 2016 – 2028
7.6.5. GCC
7.6.5.1. Market estimates and forecast with Growth rate analysis, 2016 – 2028
7.6.6. South Africa
7.6.6.1. Market estimates and forecast with Growth rate analysis, 2016 – 2028
7.6.7. Rest of Middle East & Africa
7.6.7.1. Market estimates and forecast with Growth rate analysis, 2016 – 2028
Section 8: Company Profile - Polymerase Chain Reaction (PCR) Market
8.1. Abbott
8.1.1. Business Overview
8.1.2. Product & Service Offering
8.1.3. Overall Revenue
8.1.4. Strategic Outlook
8.2. BIO-RAD LABORATORIES, INC.
8.2.1. Business Overview
8.2.2. Product & Service Offering
8.2.3. Overall Revenue
8.2.4. Strategic Outlook
8.3. THERMO FISHER SCIENTIFIC, INC.
8.3.1. Business Overview
8.3.2. Product & Service Offering
8.3.3. Overall Revenue
8.3.4. Strategic Outlook
8.4. QIAGEN
8.4.1. Business Overview
8.4.2. Product & Service Offering
8.4.3. Overall Revenue
8.4.4. Strategic Outlook
8.5. AGILENT TECHNOLOGIES, INC.
8.5.1. Business Overview
8.5.2. Product & Service Offering
8.5.3. Overall Revenue
8.5.4. Strategic Outlook
8.6. CYTIVA (GE HEALTHCARE)
8.6.1. Business Overview
8.6.2. Product & Service Offering
8.6.3. Overall Revenue
8.6.4. Strategic Outlook
8.7. F. HOFFMANN-LA ROCHE LTD.
8.7.1. Business Overview
8.7.2. Product & Service Offering
8.7.3. Overall Revenue
8.7.4. Strategic Outlook
8.8. BIOMÉRIEUX SA
8.8.1. Business Overview
8.8.2. Product & Service Offering
8.8.3. Overall Revenue
8.8.4. Strategic Outlook
8.9. DANAHER CORPORATION
8.9.1. Business Overview
8.9.2. Product & Service Offering
8.9.3. Overall Revenue
8.9.4. Strategic Outlook
8.10. STILLA
8.10.1. Business Overview
8.10.2. Product & Service Offering
8.10.3. Overall Revenue
8.10.4. Strategic Outlook
8.11. MICROSYNTH AG
8.11.1. Business Overview
8.11.2. Product & Service Offering
8.11.3. Overall Revenue
8.11.4. Strategic Outlook
8.12. FLUIDIGM CORPORATION
8.12.1. Business Overview
8.12.2. Product & Service Offering
8.12.3. Overall Revenue
8.12.4. Strategic Outlook
8.13. JN MEDSYS
8.13.1. Business Overview
8.13.2. Product & Service Offering
8.13.3. Overall Revenue
8.13.4. Strategic Outlook
*Market size and forecast will be provided from 2016-2028, and the forecast period would be 2022-2028
*Details on financial performance and strategic moves and developments may not be captured for unlisted companies
*List of companies profiled in this TOC is tentative and may change after a detailed analysis
